Résultats de la recherche - 14 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
Starrfelt; Toon Braeye; Izaak Van Evercooren; Joris Van Loenhout; Ala'a AlKerwi; Susanne Schmitz Source: European Centre for Disease Prevention and Control, Stockholm, Sweden, p.36 (2023) ISBN: ...
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
Matthieu Billuart; Toon Braeye Source: Sciensano, Brussels, Belgium, p.8 (2023) Accession Number: NA URL: https://covid-19.sciensano.be/sites/default/files/Covid19/Vaccine%20effectiveness%20of%20the%202nd%20 ...
Vaccinatiegraad en epidemiologische impact van de COVID-19-vaccinatiecampagne bij personen met onderliggende gezondheidsaandoeningen in België
Xavier Rygaert; Toon Braeye; Elias Vermeiren; Joris Van Loenhout Source: Sciensano, Brussels, Belgium, p.39 (2023) Accession Number: D/2023.14.440/38 URL: https://covid-19.sciensano.be/sites/default/files/Covid ...
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les personnes présentant des maladies sous-jacentes en Belgique
Xavier Rygaert; Toon Braeye; Elias Vermeiren; Joris Van Loenhout Source: Sciensano, Brussels, Belgium, p.39 (2023) Accession Number: D/2023.14.440/37 URL: https://covid-19.sciensano.be/sites/default/files/Covid ...
Evaluation of quality and non-clinical data for licencing of vaccines
Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: WHO GLO product evaluation course, NA, Issue WHO, NA (2013) Keywords: data EVALUATION Quality vaccine ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
World-health-organization Abstract: Adjuvants are a specific group of vaccine/medicinal product compounds, since they are not classified as active substance but have more than just a stabilising activity. According to the ...
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
Publication Type: Peer reviewed scientific article Authors: Tanghe, A; D'Souza, S; Rosseels, V; Denis, O; Ottenhoff, T H; Dalemans, W; Wheeler, C; Huygen, K Source: Infect Immun, Volume 69, ...
Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.
Publication Type: Peer reviewed scientific article Authors: Tanghe, A; Denis, O; Bénédicte Lambrecht; Motte, V; Thierry van den Berg; Huygen, K Source: Infect Immun, Volume 68, Issue 7, Number 3860, ...
Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis.
Infect. Immun. 61:2687-2693, 1993). These monoclonal antibodies were used to screen an M. bovis BCG genomic library made in phage lambdagt11. The gene encoding a 233-amino-acid (aa) protein, including ...
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.
Publication Type: Peer reviewed scientific article Authors: Baldwin, S L; D'Souza, C D; Orme, I M; Liu, M A; Huygen, K; Denis, O; Tang, A; Zhu, L; Montgomery, D; Ulmer, J B Source: Tuber Lung ...